France vs Singapore: Immunization, HepB3
France
96.0%
in 2024
Singapore
96.0%
in 2024
France rank
42nd
Singapore rank
42nd
Immunization, HepB3 over time
- France
- Singapore
How they compare
France currently reports 96.0% against 96.0% in Singapore, a difference of 0.0%.
Across all 27 years both countries report, Singapore has been ahead every year.
France ranks 42nd and Singapore ranks 42nd of 188 countries.
Singapore has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | France | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 25.5% | 96.0% | 70.5% | Singapore |
| 2000s | 36.0% | 95.6% | 59.6% | Singapore |
| 2010s | 83.2% | 96.4% | 13.2% | Singapore |
| 2020s | 95.8% | 96.6% | 0.8% | Singapore |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hepb3, France or Singapore?
- France, at 96.0% against 96.0% in Singapore as of 2024.
- What is the difference in immunization, hepb3 between France and Singapore?
- 0.0%, with France ahead.
- How many years of comparable data are there for France and Singapore?
- 27 years are reported by both, from 1998 to 2024.
- How do France and Singapore rank globally for immunization, hepb3?
- France ranks 42nd and Singapore ranks 42nd of 188 countries.
- Where does this data come from?
- World Health Organization (WHO), published as Immunization, HepB3 (% of one-year-old children). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization rate, hepatitis B is the percentage of children ages 12-23 months who received hepatitis B vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized after three doses.